Showing 461-470 of 7364 results for "".
Injectable Pearl: Microcannulas
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/injectable-pearl-microcannulas/19087/The microcannula is changing the art of aesthetic injectables but it's not right in very situation. Key to success is knowing when to use the cannula versus a needle, says Julius Few, MD.DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's latesGoogle Plus- How it benefits your Dental and Medical Practice Online
https://practicaldermatology.com/topics/practice-management/google-plus-how-it-benefits-your-dental-and-medical-practice-online/19133/Google Plus is a rapidly growing social media platform for medical, dental and even veterinarian practices. If your practice has yet to set up a Google Plus account, it would be quite beneficial to do so. Today many consumers make their decisions online, on whether they'll go with a certain doctor,Tips for dealing with patients and the media offered by Dr. Joel Schlessinger
https://practicaldermatology.com/topics/practice-management/tips-for-dealing-with-patients-and-the-media-offered-by-dr-joel-schlessinger/19155/In an increasingly connected world, business professionals must be aware of how negative customer experiences can quickly and easily be shared through the internet and social media. Dermatology is no different and Dr. Joel Schlessinger has heard of many cases in which a practice's reputation has sufCritical Factors to Advancing Melanoma Diagnosis and Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/critical-factors-to-advancing-melanoma-diagnosis-and-treatment/22970/Dermatologists need to stay abreast of technologies for evaluation of lesions and ensure that medical oncologists within their referral network recognize the importance of clinical trials.ASDS Survey: 8 Million Procedures in 2012
https://practicaldermatology.com/topics/practice-management/asds-survey-8-million-procedures-in-2012/19259/"More and more people are seeking care from dermatologic surgeons." ASDS President Timothy Flynn, MD addresses new findings about the public's dependence on dermatologic surgeons. Derm surgeons' expertise and training in cosmetic and medical care are discussed.Going Digital: Marketing for the 21st Century
https://practicaldermatology.com/topics/practice-management/going-digital-marketing-for-the-21st-century/22911/Efficient analysis and use of practice data will generate much larger returns on investment for aesthetic and medical practices.Mayo Clinic Center for Social Media: Optimizing Opportunities
https://practicaldermatology.com/topics/practice-management/mayo-clinic/19359/Experts from the Mayo Clinic Center for Social Media (socialmedia.mayoclinic.org/) offer tips for optimizing social media.What Do New PhRMA Guidelines Mean for Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0309_04-php/22858/Revisions to the "Code on Interactions" are taking effect, but what do they really mean for the typical clinician?Journal Club: Oral JAK Inhibitors in Moderate-to-Severe AD
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-oral-jak-inhibitors-moderate-severe-ad/24539/Peter Lio, MD, talks with Robert Sidbury, MD, MPH, a dermatologist at Seattle Children's Hospital, about nuanced differences in guideline-recommended use of oral JAK inhibitors in pediatric patients with moderate-to-severe atopic dermatitis (AD) provided in the Annals of Allergy, Asthma, and Immunol